Surprisingly the share price is still not moving much.
Synairgen has only 15% interest in the LOXL2 and Pharmaxis has 85%, but yesterday Synairgen rose 18%.
This company has cash, products already on the market, existing NASH deal with pharmas potentially bring in hundreds of millions of payment, and the MC is still at 100m.
Ann: Pharmaxis Announces LOXL2 Program Phase 2 Ready, page-4
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
-0.002(8.00%) |
Mkt cap ! $27.46M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.3¢ | $46.09K | 1.862M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 216878 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 311816 | 2 |
View Market Depth
| Last trade - 15.59pm 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.4¢ |
Change
-0.002 ( 1.64 %) |
||||
| Open | High | Low | Volume | ||
| 2.6¢ | 2.6¢ | 2.4¢ | 271672 | ||
| Last updated 13.44pm 11/06/2024 ? | |||||
| SNT (ASX) Chart |